2025 Regular SessionKentucky Legislature

HB648: AN ACT relating to liability shield products and declaring an emergency.

Legislative Summary

Create a new section of KRS Chapter 217 to define terms; require a manufacturer of a liability shield product to subject the product to a placebo-controlled study before it is manufactured, marketed, distributed, or administered in Kentucky; establish requirements for the placebo-controlled study; require the Cabinet for Health and Family Services to monitor and track adverse outcomes of liability shield products; require manufacturers of liability shield products to submit documentation to the cabinet of the placebo-controlled study and results of the study; provide that an individual has right to refuse a liability shield product; permit the Attorney General to bring actions for violations; permit individuals to bring actions for injuries; EMERGENCY.

Demographic Impact

Overall analysis of equity impact

60% Positive
Medium ConfidenceView detailed demographic breakdown ↓

Unlock Full Demographic Insights

Go beyond the overall score.

Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.

Enable full analysis features for your organization.

Contact Sales to Learn More

Or email us directly at sales@legiequity.us.

Bill History

2/18/2025
introduced in House
House of Representatives
2/18/2025
to Committee on Committees (H)
House of Representatives
2/26/2025
to Health Services (H)
House of Representatives

Status Information

Current Status
Introduced(2/18/2025)
Chamber
House of Representatives
Committee
Health Services(House of Representatives)

Sponsors

Republican: 2

Co-Sponsors (1)

Documents

Introduced
Bill Text1/1/197029.2 KB